April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Disruption of TGF-β Signaling Improves Dry Eye Disease
Author Affiliations & Notes
  • Cintia S. De Paiva
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • Eugene Volpe
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • Niral B. Ghandi
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • John D. Pitcher, III
    Jules Stein Eye Institute, University of California, Los Angeles, Los Angeles, California
  • William J. Farley
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • De-Quan Li
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • Michael E. Stern
    Biological Sciences, Allergan, Inc, Irvine, California
  • Jerry Y. Niederkorn
    Ophthalmology, Univ Texas Southwestern Med Ctr, Dallas, Texas
  • Stephen C. Pflugfelder
    Ophthalmology, Baylor College of Medicine, Houston, Texas
  • Footnotes
    Commercial Relationships  Cintia S. De Paiva, Allergan Inc. (F); Eugene Volpe, None; Niral B. Ghandi, None; John D. Pitcher, III, None; William J. Farley, None; De-Quan Li, None; Michael E. Stern, Allergan Inc. (E); Jerry Y. Niederkorn, None; Stephen C. Pflugfelder, Allergan Inc. (F)
  • Footnotes
    Support  NIH Grant EY018888 (CSDP), EY11915 (SCP), Research to Prevent Blindness, the Oshman Foundation, William Stamps Farish Fund, Allergan and the Hamill Foundation
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 3770. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Cintia S. De Paiva, Eugene Volpe, Niral B. Ghandi, John D. Pitcher, III, William J. Farley, De-Quan Li, Michael E. Stern, Jerry Y. Niederkorn, Stephen C. Pflugfelder; Disruption of TGF-β Signaling Improves Dry Eye Disease. Invest. Ophthalmol. Vis. Sci. 2011;52(14):3770.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : We hypothesize that transforming growth factor β (TGF-β) is critical to the immune phenotype observed in dry eye. The purpose of this study was to study the response to desiccating stress in the dominant-negative TGF-β type II receptor (CD4-DNTGFβRII) mice. These mice have a truncated TGF-β receptor type II in CD4+ T cells, rending them unresponsive to TGF-β.

Methods: : Desiccating stress (DS) was induced by subcutaneous injection of scopolamine and exposure to a drafty low humidity environment in CD4-DNTGFβRII and wild-type (WT) mice, aged 14 weeks, for 5 days. Non-stressed (NS) control mice were maintained in a separate room containing 50-75% relative humidity without exposure to forced air. Corneal smoothness was assessed by reflection of a ring light. Corneal barrier function was assessed using fluorescent Oregon-Green Dextran (OGD). Conjunctival goblet cell density was counted in periodic acid Schiff stained sections. Immunohistochemistry evaluated CD4 and CD8 T cell infiltration of the conjunctiva. T helper (Th)-1, 2 and 17 associated cytokines were evaluated in conjunctiva by real time PCR.

Results: : After desiccating stress, WT mice showed an increase in OGD staining, cornea irregularity, a decrease in PAS+ goblet cells and an increased T cell infiltration in the conjunctiva than NS WT mice. Non-stressed CD4-DNTGFβRII mice exhibited a spontaneous dry eye phenotype; however, desiccating stress improved their corneal barrier function and corneal surface irregularity, increased their number of conjunctival PAS+ cells, and lowered CD4+T cell infiltration in conjunctiva. In contrast to WT, CD4-DNTGFβRII mice were unable to generate a Th-17 and Th-1 response, and they failed to upregulate MMP-9, IL-23, IL-17A, RORγT, IFN-γ and T-bet mRNA transcripts in conjunctiva.

Conclusions: : Disruption of TGF-β signaling in CD4+ T cells causes paradoxical improvement of dry eye disease in mice subjected to desiccating stress.

Keywords: cornea: tears/tear film/dry eye • immunomodulation/immunoregulation • inflammation 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×